Correlation Between United Therapeutics and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both United Therapeutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining United Therapeutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between United Therapeutics and Larimar Therapeutics, you can compare the effects of market volatilities on United Therapeutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in United Therapeutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of United Therapeutics and Larimar Therapeutics.
Diversification Opportunities for United Therapeutics and Larimar Therapeutics
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between United and Larimar is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding United Therapeutics and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and United Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on United Therapeutics are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of United Therapeutics i.e., United Therapeutics and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between United Therapeutics and Larimar Therapeutics
Given the investment horizon of 90 days United Therapeutics is expected to generate 1.5 times less return on investment than Larimar Therapeutics. But when comparing it to its historical volatility, United Therapeutics is 2.75 times less risky than Larimar Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 633.00 in Larimar Therapeutics on August 27, 2024 and sell it today you would earn a total of 0.00 from holding Larimar Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
United Therapeutics vs. Larimar Therapeutics
Performance |
| Timeline |
| United Therapeutics |
| Larimar Therapeutics |
United Therapeutics and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with United Therapeutics and Larimar Therapeutics
The main advantage of trading using opposite United Therapeutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if United Therapeutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |